Remove 2001 Remove Marketing Remove Molecular Biology
article thumbnail

Levers for Biological Progress

Codon

I’ve chosen these two because I think they are the linchpin by which we’ll be able to build broadly useful AI models for cell and molecular biology. But looking ahead to the second bottleneck, what does it mean to say that biology is “complex”? The cost of sequencing a human genome.

DNA 132
article thumbnail

Medicinal Chemistry In The Age Of Artificial Intelligence

LifeSciVC

In 2001, I was at Millennium Pharmaceuticals, one of the major players in the nascent field of genomics drug discovery, and that time has strong parallels to the changing state of drug development today. In fact, the Millennium of 2001 (pre-Takeda acquisition) had one drug approved which was Velcade (bortezomib).

article thumbnail

The role of anti-viral drug development in a new pandemic era

Drug Target Review

Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens. This support is essential if there is likely no established commercial market for that drug. 29, 2023] | U.S.